Disordered Leptin signaling in the retrotrapezoid nucleus is associated with the impaired hypercapnic ventilatory response in obesity

The highly pathogenic H5N1 (HK483) viral infection causes a depressed hypercapnic ventilatory response (dHCVR, 20%↓) at 2 days postinfection (dpi) and death at 7 dpi in mice, but the relevant mechanisms are not fully understood. Glomus cells in the carotid body and catecholaminergic neurons in locus coeruleus (LC), neurokinin 1 receptor (NK1R)-expressing neurons in the retrotrapezoid nucleus (RTN), and serotonergic neurons in the raphe are chemosensitive and responsible for HCVR. We asked whether the dHCVR became worse over the infection period with viral replication in these cells/neurons. Mice intranasally inoculated with saline or the HK483 virus were exposed to hypercapnia for 5 min at 0, 2, 4, or 6 dpi, followed by immunohistochemistry to determine the expression of nucleoprotein of H5N1 influenza A (NP) alone and coupled with 1) tyrosine hydroxylase (TH) in the carotid body and LC, 2) NK1R in the RTN, and 3) tryptophan hydroxylase (TPH) in the raphe. HK483 viral infection blunted HCVR by ∼20, 50, and 65% at 2, 4, and 6 dpi. The NP was observed in the pontomedullary respiratory-related nuclei (but not in the carotid body) at 4 and 6 dpi, especially in 20% of RTN NK1R, 35% of LC TH, and ∼10% raphe TPH neurons. The infection significantly reduced the local NK1R or TPH immunoreactivity and population of neurons expressing NK1R or TPH. We conclude that the HK483 virus infects the pontomedullary respiratory nuclei, particularly chemosensitive neurons in the RTN, LC, and raphe, contributing to the severe depression of HCVR and respiratory failure at 6 dpi.

Download Full-text

Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine

Anesthesiology ◽

10.1097/aln.0000000000003441 ◽

2020 ◽

Vol 133 (3) ◽

pp. 559-568 ◽

Cited By ~ 5

Author(s):

Albert Dahan ◽

C. Jan van Dam ◽

Marieke Niesters ◽

Monique van Velzen ◽

Michael J. Fossler ◽

...

Keyword(s):

Utility Function ◽

Respiratory Depression ◽

Receptor Agonist ◽

Ventilatory Response ◽

Cold Pressor Test ◽

Cold Pressor ◽

Population Pharmacokinetic ◽

Potency Ratio ◽

Analgesic Effects ◽

Hypercapnic Ventilatory Response

Background To improve understanding of the respiratory behavior of oliceridine, a μ-opioid receptor agonist that selectively engages the G-protein–coupled signaling pathway with reduced activation of the β-arrestin pathway, the authors compared its utility function with that of morphine. It was hypothesized that at equianalgesia, oliceridine will produce less respiratory depression than morphine and that this is reflected in a superior utility. Methods Data from a previous trial that compared the respiratory and analgesic effects of oliceridine and morphine in healthy male volunteers (n = 30) were reanalyzed. A population pharmacokinetic–pharmacodynamic analysis was performed and served as basis for construction of utility functions, which are objective functions of probability of analgesia, P(analgesia), and probability of respiratory depression, P(respiratory depression). The utility function = P(analgesia ≥ 0.5) – P(respiratory depression ≥ 0.25), where analgesia ≥ 0.5 is the increase in hand withdrawal latency in the cold pressor test by at least 50%, and respiratory depression ≥ 0.25 is the decrease of the hypercapnic ventilatory response by at least 25%. Values are median ± standard error of the estimate. Results The two drugs were equianalgesic with similar potency values (oliceridine: 27.9 ± 4.9 ng/ml; morphine 34.3 ± 9.7 ng/ml; potency ratio, 0.81; 95% CI, 0.39 to 1.56). A 50% reduction of the hypercapnic ventilatory response by morphine occurred at an effect-site concentration of 33.7 ± 4.8 ng/ml, while a 25% reduction by oliceridine occurred at 27.4 ± 3.5 ng/ml (potency ratio, 2.48; 95% CI, 1.65 to 3.72; P < 0.01). Over the clinically relevant concentration range of 0 to 35 ng/ml, the oliceridine utility function was positive, indicating that the probability of analgesia exceeds the probability of respiratory depression. In contrast, the morphine function was negative, indicative of a greater probability of respiratory depression than analgesia. Conclusions These data indicate a favorable oliceridine safety profile over morphine when considering analgesia and respiratory depression over the clinical concentration range. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New

Download Full-text

Antagonism of Orexin Receptor 1 (OX1) in the Locus coeruleus (LC) decreases the Hypercapnic Ventilatory Response in Unanesthetized Rats during Wakefulness

The FASEB Journal ◽

10.1096/fasebj.29.1_supplement.860.7 ◽

2015 ◽

Vol 29 (S1) ◽

Author(s):

Mariane Vicente ◽

Mirela Dias ◽

Kenia Bicego ◽

Luciane Gargaglioni

Keyword(s):

Locus Coeruleus ◽

Ventilatory Response ◽

Hypercapnic Ventilatory Response

Download Full-text

Human corticotropin-releasing hormone and thyrotropin-releasing hormone modulate the hypercapnic ventilatory response in humans

European Journal of Clinical Investigation ◽

10.1046/j.1365-2362.1996.2130573.x ◽

1996 ◽

Vol 26 (11) ◽

pp. 989-995 ◽

Cited By ~ 5

Author(s):

R. SCHULZ ◽

M. NINK ◽

G. S. WERNER ◽

S. ANDREAS ◽

H. KREUZER ◽

...

Keyword(s):

Ventilatory Response ◽

Thyrotropin Releasing Hormone ◽

Corticotropin Releasing Hormone ◽

Releasing Hormone ◽

Hypercapnic Ventilatory Response

Download Full-text

Effects of Chronic Acid-Base Changes on the Rebreathing Hypercapnic Ventilatory Response in Man

Respiration ◽

10.1159/000195923 ◽

1991 ◽

Vol 58 (3-4) ◽

pp. 181-185 ◽

Cited By ~ 13

Author(s):

Ami Oren ◽

Brian J. Whipp ◽

Karlman Wasserman

Keyword(s):

Ventilatory Response ◽

Acid Base ◽

Hypercapnic Ventilatory Response

Download Full-text

Invited Editorial on “Effects of chest wall vibration on breathlessness during hypercapnic ventilatory response”

Journal of Applied Physiology ◽

10.1152/jappl.1998.84.5.1485 ◽

1998 ◽

Vol 84 (5) ◽

pp. 1485-1486 ◽

Cited By ~ 3

Author(s):

Harold Manning

Keyword(s):

Chest Wall ◽

Ventilatory Response ◽

Hypercapnic Ventilatory Response

Download Full-text

Effect of intravenous dopamine on hypercapnic ventilatory response in humans

Journal of Applied Physiology ◽

10.1152/jappl.1983.55.5.1418 ◽

1983 ◽

Vol 55 (5) ◽

pp. 1418-1425 ◽

Cited By ~ 21

Author(s):

D. S. Ward ◽

J. W. Bellville

Keyword(s):

Carbon Dioxide ◽

Ventilatory Response ◽

Carbon Dioxide Concentration ◽

Carbon Dioxide Tension ◽

Model Parameters ◽

Loop Gain ◽

Loop Contribution ◽

Dopamine Infusion ◽

Hypercapnic Ventilatory Response ◽

End Tidal

This study assessed the effect of low-dose intravenous dopamine (3 micrograms X kg-1 X min-1) on the hypercapnic ventilatory response in humans. Six normal healthy subjects were studied. By manipulating the inspired carbon dioxide concentration, the end-tidal carbon dioxide tension was raised in a stepwise fashion from 41 to 49 Torr and held at this level for 4 min. The end-tidal CO2 tension was then lowered back to 41 Torr in a stepwise fashion. The end-tidal O2 tension was held constant at 106 Torr throughout the experiment. The ventilatory response to this normoxic hypercapnic stimulus was analyzed by fitting two exponential functions, allowing the response to be separated into slow and fast chemoreflex loops. Each loop is described by a gain, time constant, and time delay. A single eupneic threshold was used for both loops. Nine control experiments and eight experiments performed during dopamine infusion were analyzed. The dopamine infusion caused the fast loop gain to be significantly (P less than 0.05) reduced from 0.64 to 0.19 l X min-1 X Torr-1, while the slow loop gain was unchanged. The fast loop contribution was reduced from 28 to 11% of the total ventilatory response. None of the other model parameters were significantly affected by the dopamine infusion. Exogenously administered dopamine substantially reduces the sensitivity of the fast chemoreflex loop to carbon dioxide.

Download Full-text